3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
7
Plasma cell
2
Other hematologic neoplasm
2
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Prostatic Neoplasms
27
Colorectal Neoplasms
9
Breast Neoplasms
9
Urinary Bladder Neoplasms
4
Lung Neoplasms
4
Neoplasms
3
Urinary Incontinence
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Thyroid Cancer, Papillary
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Prostate Cancer Patients
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplastic Syndromes, Hereditary
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Genetic Predisposition to Disease
1
Gastrointestinal Neoplasms
1
Endometrial Neoplasms
1
Disease
1
Death
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Interventions
Cyclophosphamide
8
pembrolizumab
6
Filgrastim
5
Busulfan
5
fludarabine phosphate
4
fludarabine
4
Nivolumab
4
Flow Cytometry
4
Antilymphocyte Serum
4
Alemtuzumab
4
Tacrolimus
3
Stem Cell Transplantation
3
Sirolimus
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Paclitaxel
3
Mycophenolic Acid
3
Melphalan
3
Dexamethasone
3
Carboplatin
3
Biopsy
3
Azacitidine
3
valspodar
2
atezolizumab
2
aldesleukin
2
X-Rays
2
Vorinostat
2
Vincristine
2
Thiotepa
2
Psychiatric Rehabilitation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Interviews as Topic
×
Genitourinary
×
Clear all
NCT06236373
2024-12-09
Survivorship
University of Modena and Reggio Emilia
Recruiting
45 enrolled